• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 421295 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414081024 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414081024 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock Investors Bid Up Shares of Halozyme Therapeutics, Up 14.0%

Published on Mon, 01/14/2013 - 13:11
By Peter Chu

Up 14.0% to $8.22, Halozyme Therapeutics (NASDAQ:HALO), is one of today's notable movers. The S&P is trading lower by 0.2% to 1,469 and the Dow is trading fractionally higher to 13,494.

Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.

Halozyme Therapeutics has overhead space with shares priced $8.22, or 4.2% below the average consensus analyst price target of $8.58. The stock should discover initial support at its 200-day moving average (MA) of $7.35 and subsequent support at its 50-day MA of $5.92.

In the past 52 weeks, Halozyme Therapeutics share prices have been bracketed by a low of $3.86 and a high of $13.50 and are now at $8.22, 113% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 3.0% while the 200-day MA has slid 1.7%.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Bullish Moving Average Cross by Group 1 ...

Today, shares of Group 1 Automotive (NYSE:GPI) have advanced above their 10-day MA of $ ...

Buyers Accumulate Shares of Entercom Com...

Entercom Communications (NYSE:ETM) is one of today's biggest movers, up 2.3% to $8.99. ...

Theravance Bullish Moving Average Crosso...

Theravance (NASDAQ:THRX) crossed over its 10-day moving average of $17.19 on a volume o ...

Watsco Makes a Move: Up 2.3%...

Watsco (NYSE:WSO) is a company whose shares are active, trading 2.3% higher to $93.81. ...

Bullish Moving Average Cross by Life Tim...

Today, shares of Life Time Fitness (NYSE:LTM) have crossed bullishly above their 10-day ...

Rowan Makes a Move: Up 2.3%...

Rowan (NYSE:RDC) is one of today's biggest movers, up 2.3% to $23.74. The Dow is up 1. ...

Sapient Bullish Moving Average Crossover...

Sapient (NASDAQ:SAPE) shares have crossed bullishly above their 10-day moving average o ...

Shares of Sohu.com Receive a Boost, Up 2...

Up 2.3% to $43.84, Sohu.com (NASDAQ:SOHU), is one of today's notable movers. The Dow J ...